Sarepta Therapeutics, Inc. has announced that Chief Executive Officer Douglas Ingram will retire by the end of 2026 or upon the appointment of a successor. The company has initiated a formal search for his replacement, according to a recent regulatory filing. Ingram has served as the head of the firm since 2017.
Sarepta CEO Douglas Ingram to retire by end of 2026
Douglas Ingram will retire as Sarepta CEO by late 2026 after a year of safety issues and job cuts. The company is now searching for his replacement.
Xurve View
洞察:
Xurve View












